Loading organizations...
HealthEquity provides technology-enabled platforms for health savings and consumer-directed benefits, specializing in Health Savings Accounts (HSAs). It also offers Flexible Spending Accounts (FSAs) and Health Reimbursement Arrangements (HRAs). These integrated solutions simplify healthcare fund management, empowering individuals to optimize their health-related spending and saving.
Stephen D. Neeleman, MD, founded HealthEquity in 2002. His core insight, developed years prior, focused on connecting health with wealth management for Americans facing healthcare costs. He established the company to offer accessible tools and services, enabling better navigation of complex healthcare financing.
Serving individuals, employers, benefits advisors, and health plan partners, HealthEquity aims to improve lives by empowering healthcare consumers. The company envisions a future where Health Savings Accounts become as common as 401(k)s, aspiring to achieve this widespread adoption by 2030, fostering greater financial wellness.
Key people at HealthEquity.
HealthEquity was founded in 2002 by Stephen Neeleman (Founder & Vice Chairman).
HealthEquity was founded in 2002 by Stephen Neeleman (Founder & Vice Chairman).
HealthEquity has 7 tracked investments across 3 companies. The latest tracked deal is $13.9M Other Equity in Peptomyc in December 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 16, 2020 | Peptomyc | $13.9M Other Equity | Guido Guidi | Alta Life Sciences, Business Angels, Cdti |
| Jun 26, 2019 | SANIFIT | $82.1M Other Equity / Series D | Marcelino Armenter | GUY Paul Nohra, Andera Partners, Damià Tormo, Forbion, Lundbeckfond Ventures, Ysios Capital |
| Sep 26, 2018 | Minoryx Therapeutics | $25.1M Series B | Philippe Monteyne | Caixa Capital Risc, Chiesi Ventures, Idinvest Partners, Kurma Partners, Roche, Sambrinvest, Sfpi, Gery Lefebvre, Ysios Capital |
| Sep 7, 2017 | Peptomyc | $5.0M Series A | Montserrat Vendrell | — |
| May 10, 2016 | Peptomyc | $1.1M Other Equity | Healthequity | — |
| Oct 1, 2015 | Minoryx Therapeutics | $22.0M Series A | Ysios Capital | Andera Partners, EQT Life Sciences, Faber, Forbion, Kurma Partners, Roche Venture Fund, Sanofi Ventures, Caixa Capital Risc, Chiesi Ventures, Idinvest Partners, Monique Schiersing |
| Nov 17, 2014 | SANIFIT | $4.5M Other Equity | Caixa Capital Risc | CDTI Innvierte, Fundaci, Institut Catal DE Finances, Somtobir |
Key people at HealthEquity.
